Chester County News and Community Website
WASHINGTON, D.C. — The U.S. Food and Drug Administration is seeking public input on expanding the use of existing approved medicines for new diseases and patient populations, part of a …
FDA Explores Wider Use of Existing Drugs for Chronic Disease Read More
WASHINGTON, D.C. — American patients could see significantly lower prescription drug costs under a new federal agreement with Regeneron that ties U.S. prices to the lowest rates paid in other …
Drug Prices Could Drop Sharply Under New Federal Deal Read More
WILMINGTON, DE — Truveris has launched a Center of Excellence to provide pharmacy cost management and benefits strategy support as prescription drug expenses and plan complexity increase.
Truveris Launches Center of Excellence to Address Pharmacy Costs Read More
WASHINGTON, D.C. — Importers of patented drugs, steel, aluminum, and copper products will face sharply higher tariffs under two presidential proclamations issued Wednesday, a move the White House says is …
Trump Orders New Tariffs on Drugs, Metals Imports Read More
WASHINGTON, D.C. — Federal health officials announced that manufacturers of 15 high-cost prescription drugs have agreed to participate in the next round of Medicare drug price negotiations, a program designed …
Drugmakers Agree to Join Next Round of Medicare Price Negotiations Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration announced new draft guidance aimed at reducing the cost and complexity of developing biosimilar medicines, a move the agency says could …
FDA Moves to Cut Costs for Biosimilar Drug Development Read More WASHINGTON, D.C. — The U.S. Food and Drug Administration is rolling out a sweeping set of initiatives aimed at reshaping the nation’s drug and food systems, launching a new pilot …
FDA Unveils Triple Push: Drug Onshoring, Cleaner Food Labels, GLP-1 Crackdown Read More
WASHINGTON, D.C. — President Donald Trump and British Prime Minister Keir Starmer have reached an agreement in principle on pharmaceutical pricing that U.S. officials say could reshape the global drug …
U.S., U.K. Strike Drug Pricing Deal Aimed at Ending Transatlantic Imbalance Read More
WILMINGTON, DE — A $30 million federal research initiative is taking aim at one of drug development’s most stubborn and costly blind spots: predicting how the human heart will respond …
Virtual Hearts, Real Stakes: $30M ARPA-H Bet Targets Drug Cardiac Risk Read More
WASHINGTON, D.C. — The United States and the United Kingdom reached a sweeping agreement in principle last week to rebalance pharmaceutical pricing between the two nations, marking a rare international …
U.S. Strikes Breakthrough Drug-Pricing Deal With U.K., Promising Major Shift in Global Pharma Costs Read More